@article{0b5fe567bb864b2882719d48b47fb591,
title = "Reply: The Urgent Need for More Cardiac Rehabilitation in the Aim to “Preserve” Patients With Heart Failure",
author = "Neil Keshvani and Ambarish Pandey and Fonarow, {Gregg C.}",
note = "Funding Information: Dr. Pandey has received research funding from the Texas Health Resources Clinical Scholarship, Gilead Sciences Research Scholar Program, and National Institute of Aging (GEMSSTAR grant 1R03AG067960-01); and serves on the advisory board of Roche Diagnostics. Dr. Fonarow has received consulting with Abbott, Amgen, AstraZeneca, Bayer, Edwards, Janssen, Merck, Medtronic, and Novartis. Dr. Keshvani has reported that he has no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. Pandey has received research funding from the Texas Health Resources Clinical Scholarship, Gilead Sciences Research Scholar Program, and National Institute of Aging (GEMSSTAR grant 1R03AG067960-01); and serves on the advisory board of Roche Diagnostics. Dr. Fonarow has received consulting with Abbott, Amgen, AstraZeneca, Bayer, Edwards, Janssen, Merck, Medtronic, and Novartis. Dr. Keshvani has reported that he has no relationships relevant to the contents of this paper to disclose.",
year = "2021",
month = aug,
doi = "10.1016/j.jchf.2021.06.003",
language = "English (US)",
volume = "9",
pages = "611",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "8",
}